104 related articles for article (PubMed ID: 25480655)
1. Detection of non-Hodgkin lymphoma by [¹⁸F]FDG-PET/CT in a patient with differentiated thyroid cancer.
Guidoccio F; Grosso M; Antonelli A
Endocrine; 2015 Sep; 50(1):260-1. PubMed ID: 25480655
[No Abstract] [Full Text] [Related]
2. Fortuitous detection of papillary carcinoma of the thyroid with F-18 FDG positron emission tomography in a patient with non-Hodgkin lymphoma.
Kim CE; Joyce JM; Patel N; Lichter J
Clin Nucl Med; 2003 Sep; 28(9):782-3. PubMed ID: 12973010
[TBL] [Abstract][Full Text] [Related]
3. Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
Nascimento C; Borget I; Al Ghuzlan A; Deandreis D; Hartl D; Lumbroso J; Berdelou A; Lepoutre-Lussey C; Mirghani H; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2015 Apr; 25(4):437-44. PubMed ID: 25633259
[TBL] [Abstract][Full Text] [Related]
4. Extensive lymph node metastases found by (18)F-FDG-PET/CT in a patient with diffuse sclerosing variant of papillary thyroid carcinoma.
Xu YH; Song HJ; Qiu ZL; Luo QY
Hell J Nucl Med; 2011; 14(2):188-9. PubMed ID: 21761030
[No Abstract] [Full Text] [Related]
5. Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
Kim MH; Ko SH; Bae JS; Lee SH; Jung CK; Lim DJ; Baek KH; Kim SH; Lee JM; Kang MI; Cha BY
Thyroid; 2013 Nov; 23(11):1452-60. PubMed ID: 23688271
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of partial volume effect-corrected F-18 FDG PET/CT for predicting I-131 accumulation in the metastatic lymph nodes of patients with thyroid carcinoma.
Maruoka Y; Abe K; Baba S; Isoda T; Kitamura Y; Mizoguchi N; Akamatsu G; Sasaki M; Honda H
Ann Nucl Med; 2013 Dec; 27(10):873-9. PubMed ID: 24002992
[TBL] [Abstract][Full Text] [Related]
7. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
8. Stage IE non-Hodgkin's thyroid lymphoma on (18)F-FDG-PET/CT.
Mehta A; Muthukrishnan A
Hell J Nucl Med; 2011; 14(2):186-7. PubMed ID: 21761029
[No Abstract] [Full Text] [Related]
9. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
[TBL] [Abstract][Full Text] [Related]
10. Detection of intraluminal tracheal metastasis of thyroid papillary carcinoma by 18F-FDG PET/CT.
Ozkan E; Araz M; Soydal C; Kucuk NO; Ibis E
Clin Nucl Med; 2012 Jun; 37(6):e160-1. PubMed ID: 22614217
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT demonstration of a liver metastasis in a patient with papillary thyroid cancer.
Mosci C; McDougall IR; Jeffrey RB; Iagaru A
Clin Nucl Med; 2012 Sep; 37(9):e234-6. PubMed ID: 22889801
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma.
Jung JH; Kim CY; Son SH; Kim DH; Jeong SY; Lee SW; Lee J; Ahn BC
PLoS One; 2015; 10(12):e0144152. PubMed ID: 26636824
[TBL] [Abstract][Full Text] [Related]
13. Diffuse pulmonary metastases with negative ¹⁸FDG positron emission tomography/computed tomography and positive post-radioiodine therapy scan of papillary thyroid cancer.
Lin YS; Liang ZY; Qiu LH; Cheng X
Chin Med J (Engl); 2012 Jan; 125(1):153-6. PubMed ID: 22340484
[TBL] [Abstract][Full Text] [Related]
14. Detection of Leptomeningeal Involvement by 18F-FDG-PET/CT in a Patient With Non-Hodgkin Lymphoma.
Fonti R; Salvatore B; De Renzo A; Nicolai E; Del Vecchio S
Clin Nucl Med; 2016 Feb; 41(2):169-72. PubMed ID: 26545028
[TBL] [Abstract][Full Text] [Related]
15. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M
Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
[TBL] [Abstract][Full Text] [Related]
16. [Value of (18)F-FDG dual head coincidence imaging in predicting the efficacy of radioiodine therapy for papillary thyroid carcinoma with cervical lymph node metastasis].
Sun YG; Feng HJ; Liu JH; Hu R; Ouyang W
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1571-4. PubMed ID: 21945769
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT in re-staging of patients with lymphoma.
Freudenberg LS; Antoch G; Schütt P; Beyer T; Jentzen W; Müller SP; Görges R; Nowrousian MR; Bockisch A; Debatin JF
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):325-9. PubMed ID: 14647988
[TBL] [Abstract][Full Text] [Related]
18. High FDG and low FLT uptake in a thyroid papillary carcinoma incidentally discovered by FDG PET/CT.
Nakajo M; Nakajo M; Kajiya Y; Jinguji M; Mori S; Aridome K; Suenaga T; Tanaka S
Clin Nucl Med; 2012 Jun; 37(6):607-8. PubMed ID: 22614200
[TBL] [Abstract][Full Text] [Related]
19. Neurolymphomatosis on 18F-FDG PET/CT: Diagnosis and Therapy Response.
Gykiere P; Jans L; Degrieck B; Goethals I
Clin Nucl Med; 2016 Feb; 41(2):142-3. PubMed ID: 26402124
[TBL] [Abstract][Full Text] [Related]
20. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]